Mauna Kea Technologies SA Sustainability Reports

Mauna Kea Technologies S.A. designs, develops, and commercializes innovative medical device imaging platforms. Its flagship technology, Cellvizio, functions as a real-time in vivo cellular endomicroscopy system to eliminate diagnostic uncertainty.

Sector: Professional & technical services

Country: France

Exchange: Euronext Paris

LEI: 5493007KMDG4MFIGJJ63

FIGI: BBG001V1K5P9

3 reports from 2018 to 2025

• Mauna Kea Technologies SA 2025 Annual Report
• Mauna Kea Technologies SA 2024 Annual Report
• Mauna Kea Technologies SA 2018 Registration Document